aminocaproic acid has been researched along with Arteriovenous Malformations, Cerebral in 2 studies
Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In summary, these data suggest that administration of εACA is a safe adjuvant therapy in the management of cranial dAVFs and CCFs that are incompletely treated endovascularly." | 1.48 | Incompletely obliterated cranial arteriovenous fistulae are safely and effectively treated with adjuvant ε-aminocaproic acid. ( Cawley, CM; Dion, JE; Grossberg, JA; Howard, BM; Prater, A; Tong, FC, 2018) |
| " We also review applications of antifibrinolytic agents to neurovascular disorders and discuss the mechanism of action, dosing strategy, contraindications, and possible complications associated with the use of EACA." | 1.31 | Adjuvant use of epsilon-aminocaproic acid (Amicar) in the endovascular treatment of cranial arteriovenous fistulae. ( Cloft, HJ; Dion, JE; Do, HM; Jensen, ME; Kallmes, DF; Lanzino, G; Marx, WF; West, K, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Howard, BM | 1 |
| Grossberg, JA | 1 |
| Prater, A | 1 |
| Cawley, CM | 1 |
| Dion, JE | 2 |
| Tong, FC | 1 |
| Kallmes, DF | 1 |
| Marx, WF | 1 |
| Jensen, ME | 1 |
| Cloft, HJ | 1 |
| Do, HM | 1 |
| Lanzino, G | 1 |
| West, K | 1 |
2 other studies available for aminocaproic acid and Arteriovenous Malformations, Cerebral
| Article | Year |
|---|---|
Incompletely obliterated cranial arteriovenous fistulae are safely and effectively treated with adjuvant ε-aminocaproic acid.
Topics: Adult; Aged; Aminocaproic Acid; Arteriovenous Fistula; Cohort Studies; Combined Modality Therapy; Em | 2018 |
Adjuvant use of epsilon-aminocaproic acid (Amicar) in the endovascular treatment of cranial arteriovenous fistulae.
Topics: Adolescent; Adult; Aged; Aminocaproic Acid; Antifibrinolytic Agents; Arteriovenous Fistula; Cerebral | 2000 |